RACHEL RESNICK: Open Payments
NPI 1326771502 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,122 in 133 payments from 32 companies in 2025. Trend: 2023 $0 · 2024 $2,415 · 2025 $3,122
Food & beverage: $3,122
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $463 |
| PFIZER INC. | 13 | $248 |
| Alexion Pharmaceuticals, Inc. | 8 | $195 |
| ARGENX US, INC. | 10 | $190 |
| Lilly USA, LLC | 9 | $188 |
| UCB, Inc. | 5 | $151 |
| EMD Serono, Inc. | 6 | $141 |
| Novartis Pharmaceuticals Corporation | 7 | $135 |
| Neurelis, Inc. | 5 | $131 |
| TG Therapeutics, Inc. | 4 | $130 |
Products named: NURTEC ODT, BOTOX, ULTOMIRIS, VYVGART HYTRULO, KESIMPTA, VALTOCO, BRIUMVI, QULIPTA.
Industry payments across CO — which companies pay providers there.
